Your browser doesn't support javascript.
loading
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer.
Simmler, Patrik; Cortijo, Cédric; Koch, Lisa Maria; Galliker, Patricia; Angori, Silvia; Bolck, Hella Anna; Mueller, Christina; Vukolic, Ana; Mirtschink, Peter; Christinat, Yann; Davidson, Natalie R; Lehmann, Kjong-Van; Pellegrini, Giovanni; Pauli, Chantal; Lenggenhager, Daniela; Guccini, Ilaria; Ringel, Till; Hirt, Christian; Marquart, Kim Fabiano; Schaefer, Moritz; Rätsch, Gunnar; Peter, Matthias; Moch, Holger; Stoffel, Markus; Schwank, Gerald.
Afiliación
  • Simmler P; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland.
  • Cortijo C; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
  • Koch LM; Institute of Biochemistry, ETH Zurich, 8093 Zurich, Switzerland.
  • Galliker P; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
  • Angori S; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Bolck HA; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Mueller C; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
  • Vukolic A; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
  • Mirtschink P; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
  • Christinat Y; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
  • Davidson NR; Department of Computer Science, ETH Zurich, 8092 Zurich, Switzerland.
  • Lehmann KV; Department of Computer Science, ETH Zurich, 8092 Zurich, Switzerland.
  • Pellegrini G; Institute of Veterinarian Science, University of Zurich, 8057 Zurich, Switzerland.
  • Pauli C; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Lenggenhager D; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Guccini I; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
  • Ringel T; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland.
  • Hirt C; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland.
  • Marquart KF; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland.
  • Schaefer M; Medical University of Vienna, Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Institute of Artificial Intelligence, 1090 Vienna, Austria.
  • Rätsch G; Department of Computer Science, ETH Zurich, 8092 Zurich, Switzerland.
  • Peter M; Institute of Biochemistry, ETH Zurich, 8093 Zurich, Switzerland.
  • Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Stoffel M; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
  • Schwank G; Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland. Electronic address: schwank@pharma.uzh.ch.
Cell Rep ; 40(8): 111266, 2022 08 23.
Article en En | MEDLINE | ID: mdl-36001976

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Transducción de Señal Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Transducción de Señal Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article